ctDNA/RNA genomic profiling in rare cancers with gene rearrangements

ctDNA/RNA genomic profiling in rare cancers with gene rearrangements - MASTER KEY Liquid

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049151

Enrollment

Registered

2022-10-08

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rare solid tumors with gene rearrangements

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 7 yrs or older. Diagnosed as a rare solid cancer with a gene rearrangement. Pharmacotherapy treatment is planned. Has results of tissue tumor biomarker test results. Written informed consent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The detection rate, types, and trend of detected gene alterations through the treatment course	—

Countries

Japan

Contacts

Public ContactHitomi Okuma

National Cancer Center Hospital Department of Medical Oncology

hsumiyos@ncc.go.jp03-3542-2511

Outcome results